Par Pharmaceuticals Revenue and Competitors

Spring Valley, NY USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Par Pharmaceuticals's estimated annual revenue is currently $379.5M per year.(i)
  • Par Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Par Pharmaceuticals has 1888 Employees.(i)
  • Par Pharmaceuticals grew their employee count by -6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.5M52-2%N/AN/A
#2
$354.3M461-2%$567.1MN/A
#3
$379.5M1888-6%N/AN/A
#4
$6.8M34-6%N/AN/A
#5
$5.4M270%N/AN/A
#6
$39.4M19615%N/AN/A
#7
$37.4M186-6%N/AN/A
#8
$7M353%N/AN/A
#9
$13.5M67-11%N/AN/A
#10
$10.9M540%N/AN/A
Add Company

Pharmaceutical Resources, Inc. (PRI) is a holding company that, through its subsidiaries, is in the business of developing, manufacturing and distributing a broad line of generic drugs in the United States. PRI operates primarily through its wholly owned subsidiary, Par Pharmaceutical, Inc., a manufacturer and distributor of generic drugs. The Company's product line consists of prescription and, to a lesser extent, over-the-counter generic drugs consisting of approximately 119 products representing various dosage strengths for 51 drugs. In addition to manufacturing its own products, the Company has strategic alliances with several pharmaceutical and chemical companies providing it with products for sale through distribution, development or licensing agreements. The Company markets its products primarily to wholesalers, retail drug store chains, drug distributors and repackagers.

keywords:N/A

N/A

Total Funding

1888

Number of Employees

$379.5M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Par Pharmaceuticals News

2022-04-19 - Scott Panagiotis Obituary (2022) - Grand Island, NE - Lincoln ...

He also worked for Novartis Consumer Health, Par Pharmaceutical, ... Most recently, he worked for Zoetis Pharmaceuticals in Charles City,...

2022-04-17 - Vasopressin Market Size And Forecast | Par Pharmaceutical ...

Par Pharmaceutical, Pfizer, Novartis, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals.

2022-04-17 - U.S. Vasopressin Market Research Provides an In-Depth ...

... Prospects till 2028 | Par Pharmaceutical, Pfizer Inc., Eagle Pharmaceuticals, Inc., Astellas Pharma Inc., Cumberland Pharmaceuticals Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$878.8M336410%N/A
#2
$3130M52626%N/A